April 04, 2024

Vapotherm Rises on Internet of Medical Things Solution Partnership

Global medical technology company, Vapotherm (OTCQX: VAPO) topped the PRISM Emerging Medical Devices Index on Wednesday, rising +15.94% in intraday trading. The company’s share price has performed strongly over the past three months after it announced a development and commercialization partnership with Onymos to create an end-to-end Internet of Medical Things solution (IoMT), in March…. [Read More]
April 04, 2024

BioStem Technologies Reports Record Revenue of $11.5M for Q4 2023

Leading regenerative medicine company, BioStem Technologies (OTC: BSEM) has reported record revenues for the fourth quarter of 2023, reaching $11.5 million, a 1,355% increase year-over-year. The company achieved gross profit of $10.9 million, adjusted EBITDA income of $1.67 million in the fourth quarter of 2023, and net revenue of $16.7 million, an increase of 143%… [Read More]
April 04, 2024

Technology Sector Leads Gains Ahead of US Employment Data

As Wall Street anticipates the upcoming US jobs report, stocks advanced, propelled by major technology firms. Treasury bonds also saw an uptick, whereas the dollar experienced a decline. On the eve of crucial employment data release, jobless claims exceeded expectations, hinting at potential job cuts. This scenario might support the Federal Reserve’s move towards rate… [Read More]
April 04, 2024

Beaming Up the AI Path: PRISM NextGen and AI Index Adds BMR and PATH

Today PRISM MarketView added two more companies to its PRISM NextGen and AI Index that tracks small and micro-cap stocks and is comprised of companies participating in segments of the technology sector, focused on the emerging next generation. Beamr Imaging, Ltd. Video encoder, transcoder and optimization solutions company Beamr Imaging, Ltd (BMR) recently presented its… [Read More]
April 03, 2024

Greenland Technologies (GTEC) Provides Green to Investors Screens Announcing Expansion of HEVI Network to North Carolina

Today’s PRISM Emerging EV Index current leader is a pioneer in technology development and manufacturing of electric industrial vehicles and drivetrain systems. Greenland Technologies Holding Corporation (GTEC) announced today the latest expansion of its rapidly growing HEVI Authorized Service Provider (ASP) national network program to North Carolina. The addition of Truck and Auto Repair in… [Read More]
April 03, 2024

IceCure Medical Files for FDA Clearance for Next-Gen Cryoablation System

IceCure Medical Ltd. (Nasdaq: ICCM) has filed a 510(k) submission with the FDA for clearance of its next-generation single probe cryoablation system, the XSense™ System and cryoprobes. “As our ProSense® single probe cryoablation system builds market traction globally, we continue to develop our technology pipeline with innovative single and multi-probe systems,” commented IceCure’s CEO, Eyal… [Read More]
April 03, 2024

PRISM Emerging AI Company Spotlight: Innodata

Shares in leading data engineering company, Innodata Inc. (Nasdaq: INOD) have risen steadily over the past five days after the company announced the release of Intelligent Insights™. The company’s share price rose a further 5.92% in morning trading on Wednesday. Intelligent Insights is a new generative AI-powered media intelligence feature integrated into Innodata’s industry-leading PR… [Read More]
walt disney co
April 03, 2024

Stocks Rally Amid Economic Data, with Focus on Federal Reserve’s Powell

Growth in US services slows, and inflation gauge hits a four-year low as hiring surges since July. The stock market saw a rebound following new economic data, which did not significantly alter the expectations for Federal Reserve rate cuts this year, despite recent worries over potential delays in policy easing. Investors, looking forward to insights… [Read More]
April 03, 2024

Lipella Pharmaceuticals Granted Type C Meeting for Rare Disease Candidate

Clinical stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) has been granted a Type C meeting request by the FDA. The company expects to meet with the regulator on May 21, 2024 to discuss its proposed Phase 2b clinical trial design for the evaluation of its lead candidate LP-10. Lipella is developing LP-10 as a potential… [Read More]